Gerben Hofman
Associate Director Study Leader at Acerta Pharma B.V. (A member of the AstraZeneca Group) | Nijmegen, Gelderland, Netherlands
Gerben Hofman’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Associate Director Study Leader at Acerta Pharma B.V. (A member of the AstraZeneca Group) in June 2021 - Present
Global Study Lead at Acerta Pharma B.V. (A member of the AstraZeneca Group) in January 2021 - June 2021
Clinical Study Lead at Acerta Pharma B.V. (A member of the AstraZeneca Group) in April 2017 - January 2021
Senior Clinical Study Manager at Nutricia Medical Nutrition in January 2013 - March 2017
Clinical Study Manager - Medical Nutrition at Danone in September 2009 - December 2012
sr CRA at Quintiles in May 2009 - September 2009
Senior CRA at Clinquest Europe in May 2008 - May 2009
CRA at Msource in September 2003 - April 2008
sr CRA at Schering-Plough in January 2008 - January 2008
Project Coordinator at Sanofi-Synthelabo in January 2003 - January 2004
Outdour Instructor at Adventure Sport Promotion (ASP - Valkenburg) in January 1998 - January 2001
Universiteit Maastricht, Master's degree
christelijke ondernemers School Pascal College - MDS
Christelijke Ondernemers Scholen Pascal College - LDS
Acerta Pharma is a European R&D centre of the AstraZeneca group dedicated to the discovery and development of novel innovative drugs for the treatment of haematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer. In 2016 AstraZeneca took a majority stake in the company and Acerta Pharma was fully acquired by AstraZeneca in 2021. We are working to develop new treatment options for patients with specific types of blood cancer. Together with our R&D colleagues of AstraZeneca in Gaithersburg, San Francisco, Boston (US), Gothenburg (SE) and Cambridge (UK) we are committed to innovative drug discovery and development, especially in the field of haematological oncology.
Discover more about Acerta Pharma B.V. (A member of the AstraZeneca Group)
Research Scientist Drug Discovery
Research Scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2021 – Present)
Director of Clinical Regulatory Writing
Director Clinical and Regulatory Writing at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2022 – Present)
Associate Director, Medicinal Chemistry
Associate Director, Medicinal Chemistry at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(August 2022 – Present)
Global Study Associate Director at Acerta Pharma (a member of the AstraZeneca group)
Global Study Associate Director at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(April 2023 – Present)
Senior Scientist at Acerta Pharma
Senior Scientist at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(May 2013 – Present)
Senior Director Study Management Acerta Pharma B.V. (A member of the AstraZeneca Group)
Senior Director Study Management Acerta Pharma (AstraZeneca) at Acerta Pharma B.V. (A member of the AstraZeneca Group)
(February 2022 – Present)
What is Gerben Hofman email address?
Email Gerben Hofman at [email protected] and [email protected]. This email is the most updated Gerben Hofman's email found in 2026.
How to contact Gerben Hofman?
To contact Gerben Hofman send an email to [email protected] or [email protected].
What company does Gerben Hofman work for?
Gerben Hofman works for Acerta Pharma B.V. (A member of the AstraZeneca Group).
What is Gerben Hofman's role at Acerta Pharma B.V. (A member of the AstraZeneca Group)?
Gerben Hofman is Associate Director Study Leader
What industry does Gerben Hofman work in?
Gerben Hofman works in the Pharmaceuticals industry.
